Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001015079-25-000014
Filing Date
2025-11-12
Accepted
2025-11-12 16:03:34
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 4835
  Complete submission text file 0001015079-25-000014.txt   6696
Mailing Address 4275 EXECUTIVE SQUARE 5TH FLOOR LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE 5TH FLOOR LA JOLLA CA 92037 8587550239
BRANDES INVESTMENT PARTNERS, LP (Filed by) CIK: 0001015079 (see all company filings)

EIN.: 330704072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A

Mailing Address 1585 BROADWAY SUITE 2376 NEW YORK NY 10036
Business Address 1585 BROADWAY SUITE 2376 NEW YORK NY 10036 212-969-3335
Grifols SA (Subject) CIK: 0001438569 (see all company filings)

EIN.: 000000000
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-86354 | Film No.: 251472516
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)